Institute Valuation
| MRES Stock | USD 0.01 0.0006 8.11% |
Institute seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Institute of Biomedical from evaluating the firm fundamentals such as Current Valuation of 198.84 K, net income of 564.67 K, and Shares Outstanding of 66.28 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Institute's price fluctuation is out of control at this time. Calculation of the real value of Institute of Biomedical is based on 3 months time horizon. Increasing Institute's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Institute pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Institute of Biomedical. Since Institute is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Institute Pink Sheet. However, Institute's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0068 | Real 0.006657 | Hype 0.01 | Naive 0.005486 |
The intrinsic value of Institute's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Institute's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Institute of Biomedical helps investors to forecast how Institute pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Institute more accurately as focusing exclusively on Institute's fundamentals will not take into account other important factors: Institute Total Value Analysis
Institute of Biomedical is now forecasted to have valuation of 198.84 K with market capitalization of 639.61 K, debt of 3.8 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Institute fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
198.84 K | 639.61 K | 3.8 M |
Institute Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Institute implies not a very effective usage of assets in December.Institute Profitability Analysis
The company reported the previous year's revenue of 1.41 M. Net Income was 564.67 K with profit before overhead, payroll, taxes, and interest of 0.About Institute Valuation
The pink sheet valuation mechanism determines Institute's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Institute of Biomedical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Institute. We calculate exposure to Institute's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Institute's related companies.Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Institute of Biomedical Research Corp. was founded in 2010 and is based in Podgorica, Montenegro with a representative office in Montreal, Canada. Institute is traded on OTC Exchange in the United States.
8 Steps to conduct Institute's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Institute's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Institute's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Institute's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Institute's revenue streams: Identify Institute's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Institute's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Institute's growth potential: Evaluate Institute's management, business model, and growth potential.
- Determine Institute's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Institute's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Institute Growth Indicators
Investing in growth stocks can be very risky. If the company such as Institute does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -56.8 M |
Additional Tools for Institute Pink Sheet Analysis
When running Institute's price analysis, check to measure Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Institute is operating at the current time. Most of Institute's value examination focuses on studying past and present price action to predict the probability of Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Institute's price. Additionally, you may evaluate how the addition of Institute to your portfolios can decrease your overall portfolio volatility.